Figure 3
From: Developmental potential of clinically discarded human embryos and associated chromosomal analysis
SNP array-based chromosome analysis of blastocysts from clinical PGD samples and discarded embryos.
Frequently-detected abnormal signals following SNP microarray analysis were analyzed by dividing the number of distinct signals by the number of abnormal signals. “PGD” refers to data from PGD patients. These data were compared with data generated from blastocysts derived from 2PN-, 0PN-, 3PN- and 2Cell-derived embryos; other abbreviations are as for Fig. 2.
